Incidence of and mortality from Bacille Calmette-Guérin (BCG) infections after BCG instillation therapy.

Pertti NurminenOtto EttalaRaija Uusitalo-SeppäläAntti NummiRiikka JärvinenKaipia AnttiPeter J Boström

Published in: BJU international (2021)

The incidence proportion of BCG infections among bladder cancer patients treated with BCG has increased in Finland up to 2.5% at a nationwide level, with a notably higher mortality rate than previously reported.

Keyphrases

risk factors
cardiovascular events
stem cells
cardiovascular disease
muscle invasive bladder cancer
cross sectional
type diabetes
bone marrow
smoking cessation